Novadoz Pharmaceuticals' Corporate Group Entity, MSN Pharmaceuticals Inc., Has Received USFDA Clearance for its State-of-the-Art Manufacturing Facility in Piscataway, NJ |
December 22, 2021 | December 2021 Bond Updates |
PISCATAWAY, N.J., Dec. 22, 2021 /PRNewswire/ -- Novadoz Pharmaceuticals is excited to announce that their corporate group entity, MSN Pharmaceuticals, has cleared USFDA audit with zero observations for their new, state-of-the-art, 200,000 sq. ft. manufacturing facility in Piscataway, NJ.... |
View more at: https://www.prnewswire.com:443/news-releases/novadoz-pharmaceuticals-corporate-group-entity-msn-pharmaceuticals-inc-has-received-usfda-clearance-for-its-state-of-the-art-manufacturing-facility-in-piscataway-nj-301449506.html |
Related News |
|